References
- Zucker AR, Meadow VVL. Pediatric critical care physicians' attitude about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia. Crit. Care Med. 1995; 23: 767–772.
- Frankel LR, Wilson CW, Demers RR, et al. A technique for the administration of ribavirin.
- Outwater KM, Meissner HC, Peterson MD. Ribavirin administration to infants receiving mechanical ventilation. Am. J. Dis. Child 1988; 142(5): 512–515.
- Smith DW, Frankel LR, Mathers LH, et al. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Engl. J. Med. 1991; 325:24–29.
- Adderley RJ. Safety of ribavirin with mechanical ventilation. Pediatr. Infect. Dis. 1990; 9:100–101.
- Report of the Committee on Infectious Diseases of the American Academy of Pediatrics. Use of Ribavirin in the Treatment of Respiratory Syncytial Virus Infection. 2nd ed. Elk Grove Village, IL: Committee on Infectious Diseases of the American Academy of Pediatrics. 1994: pp. 570–575.
- Moler F and Brady KP. Comment. N. Engl. J. Med. 1991; 325(26): 1184–1186.
- Granger CD and Demers RT. The ribavirin debate. Letter to the editor. Pediatrics 1996; 98(5): 1002–1004.
- Hulseman ML, Norman LA. The Neonatal ICU graduate: Part 1. Common problems. Am. FANI Physician 1992; 45(3): 1301–1305.
- Pollack MM, Ruttiman UE, Geston PR. The pediatric risk of mortality (PRISM) score. Crit.Care Med. 1988; 16:1110–1116.
- Demers RR, Parker J, Frankel LR, Smith DW. Administration of the antiviral agent ribavirin to pediatric/neonatal patients during pressure or volume present mechanical ventilation. Demers Consulting Services, PO Box 2326, Stanford CA.
- Randolph AG, Wang EEL. Ribavirin for respiratory syncytial virus lower respiratory tract infection: a systemic overview. Arch. Pediatr. Adolesc. Med. 1996; 150: 942–947.
- Meert KL, Sarnaik AP, Gelmini MJ, et al. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A pros-pective, double-blind, randomized trial. Crit. Care Med. 1994; 22: 566–572.
- Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J. Pediatr. 1990; 117: 792–798.
- Neilson KA, Yunis EJ. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr. Pathol. 1990; 10:491–502.
- Yeh TS, Pollack MM, Holbrook PR, et al. Validation of a physiologic stability index for use in critically ill infants and children. Pediatr. Res. 1984; 18: 445–451.
- Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell GL, Douglas RG, Jr, Bennett JE (eds). Principles and Practice of Infectious Diseases 4th Edn., New York; Churchill Livingstone 1995; pp 1501–1519.
- Rodriguez VVJ, Gruber WC, et al, and the Virus Immune Globulin Study Group. Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for severe RSV Infections. Pediatrics 1997; 99(3): 454–461.
- Welliver RC. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory virus infection. Sem. Perinatol. 1988; 122(1): 87–95.